USPTO 2015–2025 USPTO PatentsView US Corporation

BASF Enzymes LLC

USPTO PatentsView assignee record — 40 granted patents across 32 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

40
Total patents granted
32
CPC technology areas
12.1
Avg claims per patent
-67%
5-year filing velocity

Portfolio overview

BASF Enzymes LLC has been granted 40 US utility patents between 2015 and 2024, placing BASF Enzymes LLC at rank #7,981 across all assignees tracked by PlainPatent. This portfolio spans 32 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.1 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, BASF Enzymes LLC is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 42.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 10 grants, compared with 30 in the 2015–2019 window — a -67% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. BASF Enzymes LLC's 12.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 32 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark BASF Enzymes LLC against peers pursuing similar technology classes.

How does BASF compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows BASF holds 40 patents — placing it at rank #7,981 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2024

0246810 2015201620172018201920202021202220232024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
BASF Enzymes LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 12.5%
2016 7 17.5%
2017 4 10.0%
2018 9 22.5%
2019 5 12.5%
2020 3 7.5%
2021 3 7.5%
2022 2 5.0%
2023 1 2.5%
2024 1 2.5%

Which technologies does BASF Enzymes LLC patent most?

Top 15 of 32 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#7,981

Across all tracked assignees

Innovation Score

42.5 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does BASF Enzymes LLC hold?
BASF Enzymes LLC holds 40 US granted patents filed between 2015 and 2024, spanning 32 technology areas.
What is BASF Enzymes LLC's Innovation Score?
BASF Enzymes LLC has an Innovation Score of 42.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does BASF Enzymes LLC focus on?
BASF Enzymes LLC's top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 34 patents. The company has filed patents in 32 CPC subclasses total.
Is BASF Enzymes LLC's patent filing rate increasing or decreasing?
BASF Enzymes LLC's recent filing velocity is -67% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for BASF Enzymes LLC's patents?
BASF Enzymes LLC's patents average 12.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the BASF Enzymes LLC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope